🔗 Share this article

A shadow market for unlicensed slimming medications is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where groups with numerous of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers market the substance there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Experts Express Worries

However, doctors and chemists have warned that the sale of what is still an unlicensed medication in the UK is worrisome and could result in individuals injecting products of unknown origin.

Several professionals said the demand for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.

Platform Response and Content Removal

Based on TikTok, the service has removed problematic material and banned related hashtags and search suggestions. The company stated it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.

Digital Trading Activities

Investigations also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of slimming results, glowing testimonials and detailed instructions for mixing or injecting at home.

After minutes of joining one group, a vendor posted contact information, where most purchases occur. The vendor sent an guidebook and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Details and Costs

Inside these groups, posts display dark colored parcels with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how much time a injector should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they can’t verify. Although the science behind retatrutide is valid, these digital versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously seen patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational product not yet approved … may expose users to potentially significant health risks”.